Safety of Stimulants Across Patient Populations: A Meta-Analysis.  Oliva HNP, Prudente TP, Mayerson TF, Mignosa MM, Oliva IO, Potenza MN, Jegede OO, Angarita GA.  JAMA Netw Open. 2025 May 1;8(5):e259492. doi: 10.1001/jamanetworkopen.2025…

Methamphetamine use among people receiving opioid agonist treatment in Australia, 2014 – 2024 (Haniene Tayeb, Amy Peacock and Rachel Sutherland, NDARC - National Drug and Alcohol Research Centre, Australien, Last update: 16 May 2025) https://www.u…

Drug Trends output: Methamphetamine use among people accessing opioid agonist treatment in Australia, 2014-2024  The Illicit Drugs Reporting System (IDRS) is a national drug monitoring system that has been conducted annually since 2000. Its pu…

Commentary on Ezard et al.: Agonist-based medications for stimulant use disorder—Distinguishing their true colours.  Tardelli, V.S. and Fidalgo, T.M. (2025), Addiction. doi.org/10.1111/add.70091 https://onlinelibrary.wiley.com/doi/full/1…

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study.  Kenefick LA, Khairy L, Hall L, Kwon K, Limberg N, K…

Amphetamines: a current epidemic.  Miller N.  Front Psychiatry. 2025 Mar 25;16:1460341. doi: 10.3389/fpsyt.2025.1460341. PMID: 40201060; PMCID: PMC11975895. https://pmc.ncbi.nlm.nih.gov/articles/PMC11975895/